Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Obesity Drugs Market Research Reports

Titlepublishedprice

Global Obesity Partnering 2010 to 2017

By Current Partnering
"...... s since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by compan......"
01-Mar-2017$1495

Obesity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... d the market and pipeline status of the drugs around the Obesity to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the hist......"
01-Jan-2017$2000

Vyvanse -Drug Insights, 2017

By Delve Insight
"...... des the Vyvanse sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Vyvanse, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Abdominal Obesity-Pipeline Insights, 2017

By Delve Insight
"...... l, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designati......"
01-Jan-2017$1250

Obesity-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Europe Orlistat Market Report 2016

By QYResearch Group
"...... es, with sales, price, revenue and market share for each player in these Countries, covering - Roche - GSK group - Teva - Sandoz(Novartis) - STADA-VN J.V.Co., Ltd - Actavis - Hexal AG - National......"
14-Nov-2016$3900

Obesity - Pipeline Review, H2 2016

By Global Markets Direct
"...... d health problems such as heart disease, diabetes and high blood pressure. The predisposing factors include age, family history, quitting smoking, lack of sleep and certain medications. Treatment includes healthy lifestyle, medications and surgery......."
09-Nov-2016$2500

United States Orlistat Market Report 2016

By QYResearch Group
"...... /> - Roche - GSK group - Teva - Sandoz(Novartis) - STADA-VN J.V.Co., Ltd - Actavis - Hexal AG - National Company for Pharmaceutical Industry - Lunan Pharmaceutical Group Corporation - ZE......"
07-Nov-2016$3800

Global Orlistat Sales Market Report 2016

By QYResearch Group
"...... ales, price, revenue and market share for each player in these regions, covering - Roche - GSK group - Teva - Sandoz(Novartis) - STADA-VN J.V.Co., Ltd - Actavis - Hexal AG - National Company for......"
31-Oct-2016$4000

Global Orlistat Market Research Report 2016

By QYResearch Group
"...... duction, price, revenue and market share for each manufacturer, covering - Roche - GSK group - Teva - Sandoz(Novartis) - STADA-VN J.V.Co., Ltd - Actavis - Hexal AG - National Company for Pharmac......"
24-Oct-2016$2900